1255MO A phase II safety and efficacy study of PM8002/BNT327 in combination with chemotherapy in patients with EGFR-mutated non-small cell lung cancer (NSCLC)

Authors:
  • YWY-L. Wu
    Y-L. Wu
  • ZWZ. Wang
    Z. Wang
  • YCY. Cheng
    Y. Cheng
  • JFJ. Fang
    J. Fang
  • XMX. Meng
    X. Meng
  • YPY. Pan
    Y. Pan
  • HZH. Zhao
    H. Zhao
  • YZY. Zhao
    Y. Zhao
  • HSH. Su
    H. Su
  • MSM. Sun
    M. Sun
  • TZT. Zhou
    T. Zhou
  • PDP. Duan
    P. Duan

Abstract
No abstract available